Skip to main content
logo
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.24
+0.05 (0.54%)
At close: Aug 10, 2026, 4:00 PM EDT
9.25
+0.01 (0.11%)
After-hours: Aug 10, 2026, 5:42 PM EDT

Ocular Therapeutix Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-301.45-265.94-193.51-80.74-71.04-6.55
Depreciation & Amortization
5.454.323.792.982.112.42
Stock-Based Compensation
53.2843.1833.1117.8316.9614.98
Other Adjustments
6.855.8432.16-2.9-8.99-73.49
Change in Receivables
0.151.74-6.21-4.85-0.19-8.88
Changes in Inventories
-0.79-0.52-0.74-0.33-0.72-0.05
Changes in Accounts Payable
1.29-0.89-0.320.58-0.621.8
Changes in Accrued Expenses
0.585.253.640.771.643.72
Changes in Unearned Revenue
--0.13-0.260.430.961
Changes in Other Operating Activities
-3.612.26-6.34-4.010.28-0.48
Operating Cash Flow
-238.24-204.88-134.68-70.23-59.6-65.55
Operating Cash Flow Growth
------
Capital Expenditures
-16.86-12.01-1.29-6.09-3.72-1.19
Sale of Property, Plant & Equipment
-0.13----
Investing Cash Flow
-16.86-11.88-1.29-6.09-3.72-1.19
Short-Term Debt Issued
---2--
Short-Term Debt Repaid
----2--
Long-Term Debt Issued
---82.47-3.72
Long-Term Debt Repaid
----26.13--4.17
Net Long-Term Debt Issued (Repaid)
---56.35--0.45
Issuance of Common Stock
462.61561.72332.11118.661.453.57
Net Common Stock Issued (Repurchased)
462.61561.72332.11118.661.453.57
Other Financing Activities
----5.18--0.28
Financing Cash Flow
462.61561.72332.11169.831.452.85
Net Cash Flow
207.51344.96196.1593.51-61.86-63.89
Free Cash Flow
-255.1-216.89-135.97-76.32-63.32-66.74
Free Cash Flow Growth
------
FCF Margin
-490.07%-417.50%-213.37%-130.59%-122.96%-153.36%
Free Cash Flow Per Share
-1.19-1.16-0.86-0.89-0.77-0.81
Levered Free Cash Flow
-315.38-267.65-195.03-30.05-71.110.21
Unlevered Free Cash Flow
-327.84-271.73-173.3-88.04-78.72-70.83
SEC Filings: 10-K · 10-Q